Posts by Sandra Ansanay-Alex
INTERVIEW – Ana Pinto
🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie du Canton de Neuchâtel has the answer.
Read MoreSwiss Biotech Day
The Swiss Biotech Day is organised from 24 to 25 April 2023 at the Congress Center Basel
Read MoreParithera raises CHF 100 000 from FIT
The Foundation for Technological Innovation (FIT) has granted a CHF 100’000 Tech Seed loan to Parithera and its ExTrace Dx solution for cancer treatment. 90% of patients die from cancer because of treatment resistance. Parithera developed an integrated in-vitro diagnostic solution for cancer treatments’ response monitoring single blood draws to better understand diagnostics and…
Read MoreNagi Bioscience won a € 2,5 million grant from the EIC Accelerator
The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology Nagi Bioscience has been bestowed the prestigious and highly selective EIC Accelerator Grant supporting breakthrough innovation in Europe, funded by the Swiss State Secretariat for Education, Research and Innovation (SERI) for Swiss Startups, for its pioneer Organism-on-Chip technology. The EPFL spin-off uses C. elegans, a small worm…
Read MoreMedical devices for Ukraine
The Ukraine Embassy launches an appeal for donations Collection points in Switzerland The war in Ukraine has thrown millions of people into exile and the health situation there is dramatic. There is a shortage of medical devices needed for basic care, transport and treatment of the wounded, and intensive care. In this context, the…
Read MoreSEED Biosciences raises CHF 400 000
The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one. The device, called Dispencell, saves precious time – up to several weeks – for life science researchers, and accelerates research in the fields of pharmaceuticals, cancer or personalized medicine. Today, finding the perfect cure for every cancer patient…
Read MoreA gene could prevent Parkinson’s disease
A mutation in the Fer2 gene causes motor deficiencies in flies The laboratory of Emi Nagoshi, Professor in the Department of Genetics and Evolution at the UNIGE Faculty of Science, uses the fruit fly, or Drosophila, to study the mechanisms of dopaminergic neuron degeneration. Her group is particularly interested in the Fer2gene, whose human…
Read MoreBioArk Monthey is expanding
A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first two buildings, BioArk I and II. BioArk III, with some 5,000m2 of floor space, including several 850m2 platforms, will house startups and companies active in the life sciences sector. The site offers unique multi-functional facilities,…
Read MoreCeidos revolutionises cell culture
The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that are based on genes, tissues, or cells. They offer groundbreaking new opportunities for the treatment of cancers, degenerative diseases, genetic disorders, and injury. But producing them is a challenge and very expensive. Leonard Barras and…
Read MoreSuperlab Suisse Lausanne
A coworking space designed for scientists Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in laboratory spaces. Superlab Suisse’s «Lab as a Service» business concept includes innovatively designed laboratory facilities, state-of-the-art equipment, professional and concierge services, as well as financing support for companies in the biotech, pharma, and medtech sectors.…
Read More